Listed

Black Diamond Therapeutics, Inc.

BDTXNasdaqCIK 1701541HealthcareFiscal year ends Dec 31

Reports and events: 109 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Black Diamond Therapeutics, Inc., Reports and events
FiledFormWhat it isAccession number
2023-05-1617:26 ET8-K5.07 Shareholder vote results0001104659-23-061486
2023-05-0907:45 ET10-QQuarterly reportPeriod 2023-03-310001701541-23-000032
2023-05-0907:43 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001701541-23-000030
2023-04-0417:16 ETDEF 14AProxy statementPeriod 2023-05-160001104659-23-041622
2023-03-0907:51 ET10-KAnnual reportPeriod 2022-12-310001701541-23-000020
2023-03-0907:46 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001701541-23-000018
2022-12-1908:20 ET8-K5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001104659-22-128050
2022-12-1208:04 ET8-K7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001104659-22-126074
2022-11-0807:12 ET10-QQuarterly reportPeriod 2022-09-300001701541-22-000037
2022-11-0807:07 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001701541-22-000034
2022-08-0907:31 ET10-QQuarterly reportPeriod 2022-06-300001701541-22-000029
2022-08-0907:26 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001701541-22-000028
2022-06-0717:14 ET8-K5.07 Shareholder vote results0001104659-22-069026
2022-05-1116:17 ET10-QQuarterly reportPeriod 2022-03-310001701541-22-000018
2022-05-1116:13 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001701541-22-000017
2022-04-2816:13 ETDEF 14AProxy statementPeriod 2022-06-070001104659-22-052245
2022-04-2509:09 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001104659-22-049317
2022-04-0707:13 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001104659-22-043424
2022-03-1716:38 ET10-KAnnual reportPeriod 2021-12-310001701541-22-000007
2022-03-1716:32 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001701541-22-000006
2022-01-1010:46 ET8-K8.01 Other events0001104659-22-002587
2022-01-1007:04 ET8-K7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001104659-22-002475
2021-11-2207:00 ET8-K5.02 Departure or appointment of officers or directors0001104659-21-142198
2021-11-0807:12 ET10-QQuarterly reportPeriod 2021-09-300001701541-21-000039
2021-11-0807:04 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001701541-21-000038
2021-08-1208:16 ET10-QQuarterly reportPeriod 2021-06-300001701541-21-000034
2021-08-1208:09 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001701541-21-000032
2021-08-1016:19 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001104659-21-102855
2021-08-0507:45 ET8-K5.02 Departure or appointment of officers or directors0001104659-21-100444
2021-06-2216:12 ET8-K5.07 Shareholder vote results0001104659-21-084116
2021-05-1917:06 ET8-K7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001104659-21-069398
2021-05-0707:19 ET10-QQuarterly reportPeriod 2021-03-310001701541-21-000025
2021-05-0707:11 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001701541-21-000024
2021-04-2716:06 ETDEF 14AProxy statementPeriod 2021-06-180001104659-21-055586
2021-04-2107:00 ET8-K5.08 Item not in the standard list0001193125-21-123584
2021-03-2507:15 ET10-KAnnual reportPeriod 2020-12-310001701541-21-000018
2021-03-2507:11 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001701541-21-000016
2021-03-1506:06 ET8-K8.01 Other events0001193125-21-080409
2021-02-0117:29 ET8-K1.01 Entry into a material agreement0001193125-21-024781
2021-01-2007:51 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001193125-21-011936
2020-12-0316:47 ETSC 13D/AOwnership report, active investor, amended0001193125-20-309605
2020-11-2317:32 ETSC 13D/AOwnership report, active investor, amended0001193125-20-299548
2020-11-1007:17 ET10-QQuarterly reportPeriod 2020-09-300001701541-20-000032
2020-11-1007:13 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001701541-20-000031
2020-09-2908:06 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001193125-20-257227
2020-09-2516:37 ETSC 13D/AOwnership report, active investor, amended0001193125-20-254645
2020-08-2116:19 ETSC 13D/AOwnership report, active investor, amended0001193125-20-227020
2020-08-1107:22 ET10-QQuarterly reportPeriod 2020-06-300001701541-20-000024
2020-08-1107:14 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001701541-20-000023
2020-05-1207:34 ET10-QQuarterly reportPeriod 2020-03-310001701541-20-000018

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 10, 2026, 16:37 ET. Listed shows no prices and gives no investment advice.